创面负压引流联合重组人生长激素治疗老年糖尿病足的疗效观察

doi:10.3969/j.issn.1671-7171.2018.07.017

Abstract
Figure/Table
References
Related Citation (6)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the effect of negative pressure and recombinant human growth hormone on senile diabetic foot. 【Methods】One hundred and two senile diabetic foot patients were randomly divided into observation group and control group with 51 cases in each group. The patients in the control group were treated with negative pressure drainage, and the patients in the observation group were treated with recombinant human growth hormone on the basis of the control group. The curative effect, wound healing, hospital stay, pain improvement and serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) were compared between the two groups before and after treatment. 【Results】 The total effective rate of treatment in the observation group was 94.12, which was significantly higher than that in the control group (76.47%), and the difference was statistically significant ( P < 0.05). The granulation tissue thickness and wound healing time in the observation group were better than those in the control group ( P < 0.05). The time of hospitalization in the observation group was shorter than that in the control group ( P < 0.05). The levels of serum IGF-1 and IGFBP-3 in the control group were not significantly changed before and after treatment ( P > 0.05), and the levels of serum IGF-1 and IGFBP-3 in the observation group increased after treatment ( P < 0.05) and were higher than those in the control group ( P < 0.05). 【Conclusion】 Negative pressure of wound combined with recombinant human growth hormone is effective in treating senile diabetic foot patients. It can promote wound healing and increase serum IGF-1 and IGFBP-3 levels, which is worthy of clinical application.

Key words： Diabetic Foot/TH Negative-Pressure Wound Therapy Human Growth Hormone

Received: 18 May 2018

PACS:

R587.29

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.jcr.net.cn/EN/10.3969/j.issn.1671-7171.2018.07.017 OR http://www.jcr.net.cn/EN/Y2018/V35/I7/1298

[1] 苏硕. 37例农村老年2型糖尿病足患者特点及护理对策[J].中国继续医学教育, 2017, 9(22):261-263.
[2] Hicks CW, Canner JK, Karagozlu H, et al . The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system correlates with cost of care for diabetic foot ulcers treated in a multidisciplinary setting[J]. J Vasc Surg, 2018, 67(5):1455-1462.
[3] 詹海娃. 老年糖尿病患者糖尿病足发病的相关因素分析[J].中华现代护理杂志, 2014, 49(10):1125-1127.
[4] 李晓岚, 王敏哲, 罗荔. 老年糖尿病足发病相关因素分析[J].中国老年学, 2012, 32(10):2062-2064.
[5] 李冰玉. 重组牛碱性成纤维细胞生长因子在老年糖尿病足患者溃疡中的应用效果及护理[J].中国卫生标准管理, 2016, 7(6):224-225.
[6] 柳岚, 叶艺艺, 闫晓洁,等. 2型糖尿病患者血清IGF-1、IGFBP-3及胰岛素水平的变化与结直肠癌关系的研究[J].热带医学杂志, 2013, 13(8):957-960.
[7] 李志红, 郭淑芹, 李亭亭,等. 糖尿病足Wagner分级方法和TEXAS大学分类法临床应用价值比较[J].中国糖尿病杂志, 2012, 4(8):469-473.
[8] Campitiello F, Mancone M, Corte AD, et al . An evaluation of an ultrasonic debridement system in patients with diabetic foot ulcers: a case series[J]. J Wound Care, 2018, 27(4):222-228.
[9] 敖文. 糖尿病足的临床特点及内科综合治疗的临床分析[J].中国现代药物应用, 2016, 10(11):189-190.
[10] Wu B, Wan X, Ma J.Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting[J]. J Diabetes, 2018, 10(4):320-327.
[11] 乐忠宏, 汤晓姣, 崔婷婷,等. 糖尿病足感染患者病原学特点及耐药性分析[J].中华医院感染学杂志, 2017, 27(3):590-592.
[12] 朱新华, 柴益民, 叶吉忠,等. 负压封闭引流和传统修复方法促进糖尿病足愈合的比较[J].中国组织工程研究, 2014, 18(34):5548-5554.
[13] 耿艳侠, 卢思英, 刘岩. 封闭负压引流技术联合游离皮片植皮在糖尿病足感染创面的应用研究[J].重庆医学, 2016, 45(9):1260-1262.
[14] 张光珍, 郭健飞, 苏旭东,等. 创面持续负压封闭引流在糖尿病足治疗中的应用[J].山东医药, 2016, 56(2):109-110.
[15] 朱琳怡, 傅育红, 莫兰. 封闭负压引流联合局部间歇给氧对糖尿病足的临床疗效观察[J].护士进修杂志, 2017, 32(20):1890-1893.
[16] 陈红梅, 付庆华, 梁绛菱. 慷舒灵与重组人生长激素治疗糖尿病足的疗效及护理[J].护理研究, 2007, 21(23):2106-2107.
[17] 曹宏, 黄德芳, 孙道崎,等. 2型糖尿病患者血清IGF-1、IGFBP-3水平与结直肠癌的关系[J].江苏医药, 2015, 41(13):1577-1578.